radiopharmtheranostics.com (RADX) Cash Money per Share

Radiopharm Theranostics - graphic logo of issuer RADX

Radiopharm Theranostics (RADX) maintains an impeccable reputation in the field of isotope therapy, as evidenced by its cash per share, which has stabilized at 0.18. The business relies on outsourcing production and logistics to accelerate innovation, while the clinical trial stage ensures that capital remains completely independent of macroeconomic fluctuations and seasonality.

Radiopharm Theranostics (RADX) - Cash per Share from 12/06/2024 to 11/20/2026

Analytical breakdowns for Radiopharm Theranostics

- cash availability and cash flow indicators:
Flagship merchandise of Radiopharm Theranostics Limited

The scale of the biotechnological business of Radiopharm Theranostics (RADX) is clearly reflected in its cash per share history. This metric compares the market value of the security with the volume of net liquidity on a per-share basis. The calculation determines the company's degree of autonomy from expensive debt capital and its protection against cash flow gaps. For a radiopharmaceutical developer, such reserves are critically important for supporting an isotope portfolio. A stable level of this indicator confirms the company's ability to fund therapeutic research without the risk of capital impairment.

Competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com